INTERNATIONAL PATENT: NEUROCRINE BIOSCIENCES, INC. FILES APPLICATION FOR "MUSCARINIC RECEPTOR AGONIST IN COMBINATION WITH A VESICULAR MONOAMINE TRANSPORTER 2 INHIBITOR, FOR USE IN THE TREATMENT OF A NEUROLOGICAL OR PSYCHIATRIC DISORDER"

GENEVA, March 11 -- NEUROCRINE BIOSCIENCES, INC. (6027 Edgewood Bend CourtSan Diego, California 92130) filed a patent application (PCT/US2025/043509) for "MUSCARINIC RECEPTOR AGONIST IN COMBINATION WITH A VESICULAR MONOAMINE TRANSPORTER 2 INHIBITOR, FOR USE IN THE TREATMENT OF A NEUROLOGICAL OR PSYCHIATRIC DISORDER" on Aug 26, 2025. With publication no. WO/2026/050236, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SINGH, Jaskaran B. (c/o Neurocrine Biosciences, Inc.6027 Edgewood Bend CourtSan Diego, California 92130)

A...